Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
This study is ongoing, but not recruiting participants.
Study NCT00374660   Information provided by Eisai Inc.

First Received on September 8, 2006.   Last Updated on March 8, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Cancer
Additional conditions recognized in this trial
Liver Neoplasms
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Neoplasms
Neoplasms by Site
Interventions listed in this trial
Irofulven + oxaliplatin
Additional drug interventions recognized in this trial
Irofulven
Oxaliplatin
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Eisai Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services